Sarcoidosis

HomePatientsLung Disease Week at the ATS2013 ▶ Sarcoidosis
Sarcoidosis

Sarcoidosis Week

Welcome to Sarcoidosis Week at the ATS!

Sarcoidosis is a chronic orphan disease that most commonly affects the lungs. It impacts many organs in the body, including the eyes, nervous system, liver and heart.

The cause of sarcoidosis remains unknown. The American Thoracic Society, together with the Foundation for Sarcoidosis Research, continues to actively work with clinicians, investigators, and patients to bring awareness to this rare disease of debilitating consequences. This “bench to bedside” mission can be accomplished by:

  • Innovative funding structures
  • Effective coalition building
  • Knowledge sharing initiatives
  • Patient engagement
  • Public and private partnerships

Through our collaborations, including grant funding, education, and advocacy, we strive to bring awareness to potential prevention strategies, provide better patient care, and identify novel therapies for sarcoidosis.
We look forward to learning from each other this week and in the future.

Patricia W. Finn, MD

Patricia W. Finn, MD
President-Elect
American Thoracic Society
Member, ATS Executive Committee

Andrea Wilson

Andrea Wilson
Co-Founder and President,
Foundation for Sarcoidosis Research
Member, ATS Public Advisory Roundtable

ATS Sarcoidosis PARtner
Foundation for Sarcoidosis Research

image

The Foundation for Sarcoidosis Research (FSR) is the nation's leading nonprofit organization dedicated to finding a cure for this disease and to improving care for sarcoidosis patients. Since its establishment in 2000, FSR has funded numerous domestic and international research efforts and has worked diligently to provide resources to thousands. FSR provides funding and collaborations for research and initiatives which focus on the understanding of sarcoidosis, addresses the causes of the disease, counters the suffering of patients, and advances the potential for a cure.